David Sinclair· PhD
Nir Barzilai (metformin longevity drug),
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Nir Barzilai (metformin longevity drug),
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I was at Yale with Ralph de Franz Oh doing metabolism actually I was looking at the mechanism of action of metformin in 1987 before it was approved for use in the United States
i'm not because i'm leading this study i i'm not pushing metformin okay again the difference between advocate and scientist okay i'm i'm doing this study okay i believe in that but i'm doing this study so i cannot tell you that it's good so i'm not going to prescribe to anyone even to my friends i'm not going to prescribe